These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 28604802

  • 1. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    Loebel M, Eckey M, Sotzny F, Hahn E, Bauer S, Grabowski P, Zerweck J, Holenya P, Hanitsch LG, Wittke K, Borchmann P, Rüffer JU, Hiepe F, Ruprecht K, Behrends U, Meindl C, Volk HD, Reimer U, Scheibenbogen C.
    PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
    [Abstract] [Full Text] [Related]

  • 2. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Huang J, Tengvall K, Lima IB, Hedström AK, Butt J, Brenner N, Gyllenberg A, Stridh P, Khademi M, Ernberg I, Al Nimer F, Manouchehrinia A, Hillert J, Alfredsson L, Andersen O, Sundström P, Waterboer T, Olsson T, Kockum I.
    Brain; 2024 Oct 03; 147(10):3573-3582. PubMed ID: 38630618
    [Abstract] [Full Text] [Related]

  • 3. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D, Nadkar M, Rajadhyaksha A, Pandit-Shende P, Surve P, Dawkar N, Khadilkar P, Patwardhan M, Kaveri S, Ghosh K, Pradhan V.
    J Med Virol; 2018 Mar 03; 90(3):559-563. PubMed ID: 28734074
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
    Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT.
    In Vivo; 2004 Mar 03; 18(2):101-6. PubMed ID: 15113035
    [Abstract] [Full Text] [Related]

  • 6. Investigation of atypical serological profiles for Epstein-Barr virus (EBV).
    Portet Sulla V, Kadi A, Mouna L, Fenaux H, Cechura H, Rafek R, Di Ciccone JL, Warnakulasuriya F, Vauloup-Fellous C.
    J Virol Methods; 2024 Sep 03; 329():115002. PubMed ID: 39067186
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T, Cetin E, Kaşifoğlu N, Kaşifoğlu T, Akgün Y.
    Mikrobiyol Bul; 2011 Oct 03; 45(4):677-83. PubMed ID: 22090298
    [Abstract] [Full Text] [Related]

  • 9. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
    Ruprecht K, Wunderlich B, Gieß R, Meyer P, Loebel M, Lenz K, Hofmann J, Rosche B, Wengert O, Paul F, Reimer U, Scheibenbogen C.
    J Neuroimmunol; 2014 Jul 15; 272(1-2):56-61. PubMed ID: 24798244
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
    Loebel M, Strohschein K, Giannini C, Koelsch U, Bauer S, Doebis C, Thomas S, Unterwalder N, von Baehr V, Reinke P, Knops M, Hanitsch LG, Meisel C, Volk HD, Scheibenbogen C.
    PLoS One; 2014 Jul 15; 9(1):e85387. PubMed ID: 24454857
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L, Giess RM, Rasche L, Pfuhl C, Wakonig K, Behrens JR, Scheibenbogen C, Bellmann-Strobl J, Paul F, Reimer U, Ruprecht K.
    J Neuroimmunol; 2016 Aug 15; 297():56-62. PubMed ID: 27397076
    [Abstract] [Full Text] [Related]

  • 16. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N, van Nierop GP, Verjans GM, Osterhaus AD, Middeldorp JM, Hintzen RQ.
    J Clin Virol; 2010 Sep 15; 49(1):26-31. PubMed ID: 20638898
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Blomberg J, Rizwan M, Böhlin-Wiener A, Elfaitouri A, Julin P, Zachrisson O, Rosén A, Gottfries CG.
    Front Immunol; 2019 Sep 15; 10():1946. PubMed ID: 31475007
    [Abstract] [Full Text] [Related]

  • 18. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
    Cameron B, Flamand L, Juwana H, Middeldorp J, Naing Z, Rawlinson W, Ablashi D, Lloyd A.
    J Med Virol; 2010 Oct 15; 82(10):1684-8. PubMed ID: 20827765
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG, Haigh TA, Croom-Carter D, Leese A, Van Wijck Y, Douglas MR, Rickinson A, Brooks JM, Taylor GS.
    PLoS Pathog; 2024 Jun 15; 20(6):e1012177. PubMed ID: 38843296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.